These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29957391)

  • 21. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
    Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
    Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
    Kasheke GDS; Holman SP; Robertson GS
    J Neuroimmunol; 2022 Sep; 370():577926. PubMed ID: 35863299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Special AT-rich sequence binding protein 1 is required for maintenance of T cell receptor responsiveness and development of experimental autoimmune encephalomyelitis.
    Akiba Y; Kuwabara T; Mukozu T; Mikami T; Kondo M
    Microbiol Immunol; 2018 Apr; 62(4):255-268. PubMed ID: 29388727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
    Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
    Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis.
    Gruber RC; Ray AK; Johndrow CT; Guzik H; Burek D; de Frutos PG; Shafit-Zagardo B
    J Neurosci; 2014 Dec; 34(49):16320-35. PubMed ID: 25471571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
    Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
    Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
    J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses.
    Zareie P; Connor B; La Flamme AC
    J Neuroinflammation; 2017 Mar; 14(1):68. PubMed ID: 28356108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
    Mitra NK; Bindal U; Eng Hwa W; Chua CL; Tan CY
    Int J Clin Exp Pathol; 2015; 8(10):12041-52. PubMed ID: 26722389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis.
    Bebo BF; Dehghani B; Foster S; Kurniawan A; Lopez FJ; Sherman LS
    Glia; 2009 May; 57(7):777-90. PubMed ID: 19031437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.